Although the specific signaling mechanism of how EphA2 regulates responses in OS cells is unknown, previous reports in other cancer types highlight a ligand-independent pro-oncogenic mode of action of the EphA2 receptor [36]. The gene discussed is EPHA2; the disease is cancer.